EHTH Quote, Financials, Valuation and Earnings

CorVel has a net margin of -72.72% compared to eHealth's net margin of 10.43%. eHealth's return on equity of -5.64% beat CorVel's return on equity of 32.6%.

eHealth has a consensus price target of $7.38, signalling downside risk potential of -6.88%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that eHealth has higher upside potential than CorVel, analysts believe eHealth is more attractive than CorVel.

eHealth has a beta of 0.473, which suggesting that the stock is 52.725% less volatile than S&P 500. In comparison CorVel has a beta of 1.139, suggesting its more volatile than the S&P 500 by 13.888%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. eHealth pays -12.52% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend.

eHealth quarterly revenues are $58.4M, which are smaller than CorVel quarterly revenues of $224.4M. eHealth's net income of -$42.5M is lower than CorVel's net income of $23.4M. Notably, eHealth's price-to-earnings ratio is -- while CorVel's PE ratio is 71.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.49x versus 6.93x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of -72.72% compared to eHealth's net margin of 17.12%. eHealth's return on equity of -5.64% beat Kingstone Companies's return on equity of 40.22%.

eHealth has a consensus price target of $7.38, signalling downside risk potential of -6.88%. On the other hand Kingstone Companies has an analysts' consensus of -- which suggests that it could grow by 12.88%. Given that Kingstone Companies has higher upside potential than eHealth, analysts believe Kingstone Companies is more attractive than eHealth.

eHealth has a beta of 0.473, which suggesting that the stock is 52.725% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.712, suggesting its less volatile than the S&P 500 by 28.819%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. eHealth pays -12.52% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend.

eHealth quarterly revenues are $58.4M, which are larger than Kingstone Companies quarterly revenues of $40.8M. eHealth's net income of -$42.5M is lower than Kingstone Companies's net income of $7M. Notably, eHealth's price-to-earnings ratio is -- while Kingstone Companies's PE ratio is 11.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.49x versus 1.19x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of -72.72% compared to eHealth's net margin of 13.11%. eHealth's return on equity of -5.64% beat Marsh & McLennan Companies's return on equity of 31.46%.

eHealth has a consensus price target of $7.38, signalling downside risk potential of -6.88%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $232.03 which suggests that it could grow by 9.36%. Given that Marsh & McLennan Companies has higher upside potential than eHealth, analysts believe Marsh & McLennan Companies is more attractive than eHealth.

eHealth has a beta of 0.473, which suggesting that the stock is 52.725% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.724%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marsh & McLennan Companies offers a yield of 1.44% to investors and pays a quarterly dividend of $0.82 per share. eHealth pays -12.52% of its earnings as a dividend. Marsh & McLennan Companies pays out 34.56% of its earnings as a dividend. Marsh & McLennan Companies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

eHealth quarterly revenues are $58.4M, which are smaller than Marsh & McLennan Companies quarterly revenues of $5.7B. eHealth's net income of -$42.5M is lower than Marsh & McLennan Companies's net income of $747M. Notably, eHealth's price-to-earnings ratio is -- while Marsh & McLennan Companies's PE ratio is 26.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.49x versus 4.40x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.

Reliance Global Group has a net margin of -72.72% compared to eHealth's net margin of -24.33%. eHealth's return on equity of -5.64% beat Reliance Global Group's return on equity of -291.14%.

eHealth has a consensus price target of $7.38, signalling downside risk potential of -6.88%. On the other hand Reliance Global Group has an analysts' consensus of -- which suggests that it could grow by 3726.37%. Given that Reliance Global Group has higher upside potential than eHealth, analysts believe Reliance Global Group is more attractive than eHealth.

eHealth has a beta of 0.473, which suggesting that the stock is 52.725% less volatile than S&P 500. In comparison Reliance Global Group has a beta of 0.178, suggesting its less volatile than the S&P 500 by 82.159%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reliance Global Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. eHealth pays -12.52% of its earnings as a dividend. Reliance Global Group pays out -- of its earnings as a dividend.

eHealth quarterly revenues are $58.4M, which are larger than Reliance Global Group quarterly revenues of $3.4M. eHealth's net income of -$42.5M is lower than Reliance Global Group's net income of -$837.3K. Notably, eHealth's price-to-earnings ratio is -- while Reliance Global Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.49x versus 0.13x for Reliance Global Group. Usually stocks with elevated PS ratios are considered overvalued.